BioSpace News Archive

Policy

Pharmascience Inc. issues voluntary recall of Ranitidine Tablets 75mg, 150mg and 300mg (all pack sizes and formats)

Pharmascience Inc. is voluntarily, on a precautionary basis, recalling Ranitidine Tablets 75mg, 150mg and 300 mg to the retail level.

October 23, 2019
·
2 min read
Deals

OpGen Announces Pricing of $9.4 Million Underwritten Offering

OpGen, Inc. announced the pricing of an underwritten offering of an aggregate of 4,700,000 units at an effective price of $2.00 per unit.

October 23, 2019
·
5 min read
Policy

More Breakthroughs in Nanotechnology Could Lead to Improvements in Drug Delivery and Medicine

Researchers have developed a precise and non-toxic nanoscale technology that can deliver oncology drugs directly to cancer cells. The minuscule tubes are called peptoids.

October 23, 2019
·
3 min read
·
Mark Terry
Drug Development

MacroGenics’ Metastatic Breast Cancer Drug Shows Survival Benefits in Phase III Trial

MacroGenics’ metastatic HER2-positive breast cancer treatment margetuximab continues to show promise following a second pre-planned interim overall survival analysis of its Phase III SOPHIA trial.

October 23, 2019
·
2 min read
·
Alex Keown
Drug Development

Good Pharma Scorecard Continues to Boost Clinical Trial Transparency, Analyst Report Shows

Calls for increased transparency in clinical trials have been growing and now many medical journals are requiring authors of submitted papers to disclose whether or not they will be sharing clinical trial results.

October 23, 2019
·
3 min read
·
Alex Keown
Genetown

New Approaches to Alzheimer’s and Tauopathies: Eikonizo Therapeutics

Janice Kranz, the company’s co-founder and chief executive officer took time to speak with BioSpace about the company and its approach to Alzheimer’s disease and other tauopathies.

October 23, 2019
·
5 min read
·
Mark Terry
Business

Pliant Inks $80 Million+ Deal with Novartis on Liver Disease NASH

The agreement revolves around the development and commercialization of Pliant’s preclinical candidate, PLN-1474, and up to three more integrin targets for liver fibrosis associated with nonalcoholic steatohepatitis.

October 23, 2019
·
3 min read
·
Mark Terry
Resurgence of Algae in Biotech: From Fuels to Foods

Because algae can grow simply on carbon dioxide and light, they are attractive to companies looking at generating protein from greenhouse gases.

October 23, 2019
·
5 min read
·
David Kirk
Business

Who are Some of the Most Influential Gen Xers in the Biotech Industry?

The five scientists on this list collectively made many exciting strides in the field, notably because they had the technological skills to embrace and utilize advances in the realm of computer programming.

October 23, 2019
·
3 min read
·
Kymberlie Krieger
BioSpace Global Roundup, Oct. 24

Life sciences companies from across Europe and Asia provide updates on their business and pipelines.

October 23, 2019
·
6 min read
·
Alex Keown